Publication | Closed Access
Homogeneous Visual and Fluorescence Detection of Circulating Tumor Cells in Clinical Samples <i>via</i> Selective Recognition Reaction and Enzyme-Free Amplification
128
Citations
32
References
2021
Year
EngineeringCirculating Tumor CellsBiomedical EngineeringBiosensing SystemsCancer DetectionBioanalysisQuantum DotsHomogeneous VisualClinical ChemistryMolecular DiagnosticsRadiation OncologyMolecular ImagingNovel Imaging MethodMedicineFluorescence ImagingBiomedical AnalysisCell BiologySingle-molecule DetectionBiomolecular EngineeringBiomedical DiagnosticsBiomedical ImagingEnzyme-free AmplificationAmplification StrategyMucin 1Cell Detection
Here we report a simple all-nucleic-acid enzyme-free catalyzed hairpin assembly assisted amplification strategy with quantum dots (QDs) as the nanoscale signal reporter for homogeneous visual and fluorescent detection of A549 lung cancer cells from clinical blood samples. This work was based on the phenomenon that CdTe QDs can selectively recognize Ag+ and C-Ag+-C and by using mucin 1 as the circulating tumor cells (CTCs) marker and aptamer as the recognition probe. Under optimized conditions, the limits of detections as low as 0.15 fg/mL of mucin 1 and 3 cells/mL of A549 cells were achieved with fluorescence signals. A 1 fg/mL concentration of mucin 1 and 100 cells/mL of A549 can be distinguished by the naked eye. This method was used to quantitatively analyze CTCs in 51 clinical whole blood samples of patients with lung cancer. The levels of CTCs detected in clinical samples by this method were consistent with those obtained using the folate receptor-polymerase chain reaction clinical test kit and correlated with radiologic and pathological findings.
| Year | Citations | |
|---|---|---|
Page 1
Page 1